Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309928 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy
A Phase 1 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT05309928 is a Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 13 participants.
The verdict
NCT05309928, a Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.
Interventions
- DRUG Amoxicillin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2025-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05309928
The ClinicalTrials.gov registry entry for NCT05309928 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amoxicillin is the first listed.
NCT05309928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05309928 about?
NCT05309928 is a clinical study titled "Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy". The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.
What is the current status of trial NCT05309928?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2023-08-29. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05309928?
The interventions under investigation include: Amoxicillin (DRUG).
Who is sponsoring clinical trial NCT05309928?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.